Nevada
|
75-3254381
|
|
(State or other jurisdiction of
|
(I.R.S. employer
|
|
incorporation or organization)
|
identification number)
|
21900 Burbank Blvd, Third Floor, Woodland Hills, CA 91367
|
(Address of principal executive offices and zip code)
|
(818) 992-3126
|
(Registrant’s telephone number, including area code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
|
·
|
Under the employment agreement currently in effect between Dr. Singh and the Company, Dr. Singh is eligible to receive an annual incentive cash bonus of up to 30% of the base salary that he earned during the 2014 calendar year. Dr. Singh’s base salary in 2014 was $350,000. Based on its evaluation of Dr. Singh’s personal objectives and the Company objectives established by the Compensation Committee, the committee decided that Dr. Singh should be paid $84,000 as his incentive compensation under his employment agreement.
|
|
·
|
The Compensation Committee also approved cash bonus payments to the following executive officers: Elma Hawkins, Ph.D., the Company’s President and Chief Operating Officer, will receive $59,583; Laszlo Radvanyi, Ph.D. will receive $36,458; James Bender, Ph.D. will receive $52,000; and Michael Handelman will receive $45,000.
|
Date: December 9, 2014
|
LION BIOTECHNOLOGIES, INC.
By:/s/ Michael Handelman_________________
Michael Handelman, Chief Financial Officer
|